Disease related to solid organ transplantation
MONDO:0700221Disease that occurs as a consequence of immunosuppression in a recipient of a solid organ transplant, or as a consequence of the transplantation.
14 clinical trials for this condition and its sub-types, 11 tagged with Disease related to solid organ transplantation itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Donor immune cells take on Virus-Linked cancer after transplant
Disease control Recruiting nowThis phase 3 trial tests tabelecleucel, a cell therapy made from donor immune cells, in 115 organ or stem cell transplant patients who developed a rare cancer (EBV+ PTLD) after standard treatment failed. The goal is to see if it can shrink tumors and improve outcomes. Participant…
Phase 3 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a bone marrow transplant free kidney patients from lifelong pills?
Disease control Recruiting nowThis early-phase trial tests a combined kidney and bone marrow transplant from the same donor to help the body accept the new kidney without needing lifelong anti-rejection drugs. Up to 12 adults with kidney failure will receive the treatment. The goal is to see if this approach …
Early phase 1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug may protect kidneys in lung transplant patients
Disease control Recruiting nowThis study tests whether giving a long-acting version of the anti-rejection drug tacrolimus early after a lung transplant can help protect kidney function while still preventing organ rejection. About 48 adults who have recently received a lung transplant will be randomly assigne…
Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a cell infusion free organ transplant patients from lifelong drugs?
Disease control Recruiting nowThis early-stage trial tests whether giving a special mix of blood cells after an organ transplant can help the body accept the new organ without needing lifelong anti-rejection drugs. About 10 children and adults receiving kidney, lung, or intestinal transplants will get the cel…
Phase 1 • Sponsor: Francisco Hernández Oliveros • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC